Novartis (REGD) Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   CHF per share 
 Price  84.04
 Dividend  2.80
 Earnings  4.80
 Cash-flow  5.35
 Book value  31.13
 Equity  32.21

Novartis (REGD) is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novartis (REGD) is a company from Switzerland, and his stocks are publicly traded.

Novartis (REGD) paid a total dividend of 6,490 million CHF last year, for a market value of 194,805 millions (Market Cap 182,762 millions). Dividend per share of Novartis (REGD) is 2.80 CHF, and his stock market price 84.04 CHF.

According to the chart below, where dividend yield is displayed, Novartis (REGD) has a dividend yield of 3.33%, which is higher than the amount offered by both the market average and companies from Switzerland. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare Novartis (REGD) dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Switzerland.

Dividend yield of Novartis (REGD)

Novartis (REGD) Dividend Payout

About the ability of Novartis (REGD) to maintain his current dividend of CHF 2.80 per share, an amount that accounts for 3.33%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novartis (REGD) payout on ernings is currently 58.33%, which is higher than the market average, and companies of Health Care industry, which are 40.41% and 28.58% respectively. Both figures show that Novartis (REGD) can have problems to keep with his present dividend yield.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novartis (REGD) is CHF 5.35 per share, which is higher than the dividend per share paid by the company of CHF 2.80, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Novartis (REGD), compared againt world market average, Switzerland companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Novartis (REGD) payout

Novartis (REGD) Stock performance

Finally, last moth Novartis (REGD) showed a return of -7.60% compared to a worldwide -5.60% average, and a -7.73% of Health Care firms. Over the last year, the company obtained a 2.00% versus a worldwide performance of a -11.41%. More detailed information can be seen in the following graph for Switzerland and Pharmaceuticals and Biotechnology firms.

Novartis (REGD) stock and market return

Next companies

Novatek Microelectro. Taiwan. Technology.

NovaTek OAO. Russia. Oil and Gas.

Novo-Nordisk B. Denmark. Health Care.

Novolipetsk Steel. Russia. Basic Materials.

Novorossiysk Commercial Sea Port. Russia. Industrials.

Novozymes A/S. Denmark. Health Care.

Previous companies

Notre Dame Intermedica. Brazil. Health Care.

Norwegian Cruise Lin. USA. Consumer Services.

Northrop Grumman Cp. USA. Industrials.

Northern Trust. USA. Financials.

Northam Platinum. South Africa. Basic Materials.

North Pacific Bank. Japan. Financials.

 

 

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.